Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
15 peer reviewed publications from 2020
Viola Previtali , Helene B Mihigo , Rebecca Amet, Anthony M McElligott , Daniela M Zisterer , Isabel Rozas , Exploring the Anti-Cancer Mechanism of Novel 3,4'-Substituted Diaryl Guanidinium Derivatives, Pharmaceuticals (Basel), 13, (12), 2020, p485
Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin‐Loeches, Paul Browne, Christopher L Bacon, Richard Gaule, Alexander Gillett, Mary Byrne, Kevin Ryan, Niamh O'Connell, Jamie M O'Sullivan, Niall Conlon, James S O'Donnell, COVID 19 coagulopathy in caucasian patients, British Journal of Haematology, 89, (6), 2020, p1044 - 1049
, The Irish Experience of Thiotepa, Carmustine and Etoposide Conditioning Prior to ASCT for the Treatment of Central Nervous System Lymphomas, BONE MARROW TRANSPLANTATION, 2020
, Real-world experience of BRAF V600E mutation testing in hairy cell leukaemia, Journal of clinical pathology, 2020
, Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring, Hematology/oncology and stem cell therapy, 2020
, A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination with Tremelimumab or Danvatirsen in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Clinical Lymphoma Myeloma and Leukemia, 2020
Orfali N., O'Donovan T.R., Cahill M.R., Benjamin D., Nanus D.M., McKenna S.L., Gudas L.J., Mongan N.P., All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL), European Journal of Haematology, 104, (3), 2020, p236 - 250, p236-250
Orfali N., Shan-Krauer D., O'Donovan T.R., Mongan N.P., Gudas L.J., Cahill M.R., Tschan M.P., McKenna S.L., Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells, Molecular Oncology, 14, (6), 2020, p1297 - 1309, p1297-1309
Orfali N., van Besien K., Combining haplo-identical and cord blood stem cell grafts"might the whole be greater than the sum of its parts?, Leukemia and Lymphoma, 61, (4), 2020, p753 - 756, p753-756
Van Besien K.W., Orfali N., Alternative donor transplantation for lymphoid malignancies: How far we have come, Journal of Clinical Oncology, 38, (14), 2020, p1501 - 1504, p1501-1504
Salvatore M., Laplante J.M., Soave R., Orfali N., Plate M., van Besien K., St. George K., Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir, Transplant Infectious Disease, 22, (4), 2020
Gomez-Arteaga A., Orfali N., Guarneri D., Cushing M.M., Gergis U., Hsu J., Hsu Y.-M.S., Mayer S.A., Phillips A.A., Chase S.A., Mokhtar A.E., Shore T.B., Van Besien K., Cord blood transplants supported by unrelated donor CD34+ progenitor cells, Bone Marrow Transplantation, 55, (12), 2020, p2298 - 2307, p2298-2307
Chaekal O.-K., Scaradavou A., Frenet E.M., Albano M.S., Cushing M., Desai P., Dobrila L., Gergis U., Guarneri D., Hsu J.-M., Lee S., Mayer S.A., Phillips A.A., Orfali N., Ritchie E.K., Roboz G.J., Romeo C., Samuel M.S., Shore T., van Besien K., Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response, Blood Advances, 4, (20), 2020, p5146 - 5156, p5146-5156
Van Besien K., Orfali N., Shore T., Allogeneic Transplant Conditioning Regimens for Patients with Non-Hodgkin Lymphoma, JAMA Oncology, 6, (12), 2020, p1980-
Ta R, Santini C, Gou P, Lee G, Tai YC, O'Brien C, Fontecha M, Grant C, Bacon L, Finn S, Vandenberghe E, Quinn F, Dua R, Flavin R., Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay , J Mol Diagn, 2020, pS1525-1578-